JF
FDMT icon

Jump Financial’s 4D Molecular Therapeutics FDMT Stock Holding History

Jump Financial’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,830
Closed -$254K – 2044
2025
Q4 		$254K Buy
+33,830
New +$343K ﹤0.01% 1633
2025
Q1 		– Sell
-94,689
Closed -$527K – 1714
2024
Q4 		$527K Buy
94,689
+19,196
+25% +$151K 0.01% 1044
2024
Q3 		$816K Buy
75,493
+46,128
+157% +$766K 0.02% 883
2024
Q2 		$616K Buy
29,365
+326
+1% +$8.18K 0.01% 1047
2024
Q1 		$925K Buy
+29,039
New +$741K 0.03% 848
2022
Q3 		– Sell
-22,500
Closed -$157K – 1695
2022
Q2 		$157K Buy
+22,500
New +$219K 0.01% 1358
2022
Q1 		– Sell
-26,593
Closed -$583K – 1655
2021
Q4 		$583K Buy
+26,593
New +$652K 0.04% 587

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return